Dr Kevin Fenix

Research Fellow

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Dr Kevin Fenix, PhD is a research fellow located at the Basil Hetzel Institute for Translational Health Research the research arm of The Queen Elizabeth Hospital. As part of the Upper GI and ENT Surgery Departments, his current research utilises both patient samples and clinically relevant in vitro and in vivo models to find new treatment modalities for infections and cancer. Dr Fenix has successfully supervised Honours, Master and PhD students to completion and is a recipient of multiple competitive research grants to support his research.

My Research
Career
Publications
Grants and Funding
Supervision
Professional Activities
Contact

My research interests include Cancer Immunotherapy, Cancer Biology, Immunobiology and Host/Microbe Interactions. This aligns with my affiliation with the Upper GI and ENT Surgery Departments at the Basil Hetzel Institute for Translational Health Research. Currently, I am identifying treatment modalities for Colorectal Cancer, Head and Neck Cancer and Chronic Rhinosinusitis.

Projects related to this work are available for HDR, Honours and Third Year Students. Potential students can apply for competitive scholarships for Honours, Masters and PhD (Top-Up) offered by the Basil Hetzel Institute.

Current projects include:

Identifying distinct tumour-infiltrating immune cells with prognostic capacity for cancer metastasis and patient survival.
Developing T cell-based therapies for cancer.
Understanding and exploiting the tumour microbiome to develop new cancer treatments.
Deciphering how the host-microbe interactions influence chronic rhinosinusitis.

Appointments

Date Position Institution name

2018 - ongoing Postdoctoral Research Fellow The University of Adelaide

Date	Position	Institution name
2018 - ongoing	Postdoctoral Research Fellow	The University of Adelaide

Awards and Achievements

Date	Type	Title	Institution Name	Country	Amount
2024	Fellowship	Cancer Council SA Mid-Career Research Fellowship	Cancer Council SA	Australia	-
2018	Fellowship	The Hospital Research Foundation Early Career Fellowship	The Hospital Research Foundation	Australia	-
2017	Award	Dean’s Commendation for Thesis Excellence	The University of Adelaide	Australia	-
2012	Scholarship	Australian Postgraduate Award	The University of Adelaide	Australia	-
2010	Research Award	Derrick Rowley Prize for Honours in Microbiology and Immunology	The University of Adelaide	Australia	-

Language Competencies

Language Competency

English Can read, write, speak, understand spoken and peer review

Filipino; Pilipino Can read, write, speak and understand spoken

Language	Competency
English	Can read, write, speak, understand spoken and peer review
Filipino; Pilipino	Can read, write, speak and understand spoken

Education

Date	Institution name	Country	Title
2017	University of Adelaide	Australia	PhD
2010	University of Adelaide, Adelaide	Australia	Bsc (Hons)
2009	University of Adelaide, Adelaide	Australia	Bsc (Biomedical Science)

Research Interests

Cancer Cell Biology Cellular Immunology Immunological and Bioassay Methods Tumour Immunology Cancer Biology and Clinical Oncology Immunology and Infection

Journals

Year	Citation
2025	Syphers, J. L., Wright, J. A., Liu, S., Gee, Y. S., Gao, F., Mudududdla, R., . . . Baell, J. B. (2025). Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids. Journal of Medicinal Chemistry, 68(8), 8065-8090. DOI
2025	Burdon, I., Bouras, G., Fenix, K., Yeo, K., Connell, J., Cooksley, C., . . . Psaltis, A. J. (2025). Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome. International Forum of Allergy and Rhinology, 4 pages. DOI
2024	Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?. Pathogens, 13(10), 826-1-826-20. DOI Scopus3 Europe PMC3
2024	Man Ying Li, C., Li, R., Drew, P., Price, T., Smith, E., Maddern, G. J., . . . Fenix, K. (2024). Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: current strategies and future challenges. Cancer Treatment Reviews, 122, 102665-1-102665-11. DOI Scopus9 Europe PMC4
2024	Connell, J. T., Yeo, K., Bouras, G., Bassiouni, A., Fenix, K., Cooksley, C., . . . Psaltis, A. J. (2024). Enhanced phylogenetic insights into the microbiome of chronic rhinosinusitis through the novel application of long read 16S rRNA gene amplicon sequencing.. Rhinology, 0(0), 0. DOI Scopus3 Europe PMC2
2024	Li, C. M. Y., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2024). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. Cancer Immunology Immunotherapy, 73(1), 6-1-6-16. DOI Scopus1 Europe PMC1
2024	Sharma, A., Ren, X., Rosato, A., Sangiolo, D., Wang, Z., Tettamanti, S., . . . Schmidt-Wolf, I. G. H. (2024). Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy. Cancer Immunology Immunotherapy, 73(2), 6 pages. DOI Scopus4 Europe PMC3
2024	Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. Journal of Medical Microbiology, 73(2), 001799-1-001799-18. DOI Scopus6 Europe PMC5
2024	Li, C. M. Y., Briggs, M. T., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.. Clin Exp Med, 24(1), 53. DOI Scopus3 Europe PMC2
2024	Houtak, G., Nepal, R., Bouras, G., Shaghayegh, G., Bennett, C., Finnie, J., . . . Vreugde, S. (2024). Staphylococcus aureus Biofilm-Secreted Factors Cause Mucosal Damage, Mast Cell Infiltration, and Goblet Cell Hyperplasia in a Rat Rhinosinusitis Model. International Journal of Molecular Sciences, 25(6), 3402-1-3402-22. DOI Scopus4 Europe PMC4
2024	Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221-1-110221-16. DOI Scopus3 Europe PMC2
2024	Yeo, K., Connell, J., Bouras, G., Smith, E., Murphy, W., Hodge, J. -C., . . . Fenix, K. A. (2024). A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues. Arch Microbiol, 206(6), 248-1-248-14. DOI Scopus9 Europe PMC6
2024	Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Diagnostic and prognostic significance of circulating secreted frizzled-related protein 5 in colorectal cancer. Cancer Medicine, 13(11), e7352-1-e7352-11. DOI Europe PMC1
2024	Connell, J. T., Bouras, G., Yeo, K., Fenix, K., Cooksley, C., Bassiouni, A., . . . Psaltis, A. J. (2024). Characterising the allergic fungal rhinosinusitis microenvironment using full-length 16S rRNA gene amplicon sequencing and fungal ITS sequencing.. Allergy, 79(11), 3082-3094. DOI Scopus4 Europe PMC1
2023	Ying Li, C. M., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. (2023). Use of cytokine-induced killer cell therapy in colorectal cancer patients: a systematic review and meta-analysis. DOI
2023	Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages. DOI Scopus3 WoS1 Europe PMC3
2023	Houtak, G., Nepal, R., Bouras, G., Shaghayegh, G., Bennett, C., Finnie, J., . . . Vreugde, S. (2023). <i>Staphylococcus aureus</i>biofilm secreted factors cause mucosal damage, mast cell infiltration and goblet cell hyperplasia in a rat rhinosinusitis model. DOI
2023	Dhakal, B., Tomita, Y., Drew, P., Price, T., Maddern, G., Smith, E., & Fenix, K. (2023). Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules, 28(8), 3624. DOI Scopus11 WoS1 Europe PMC10
2023	Li, C. M. Y., Tomita, Y., Dhakal, B., Li, R., Li, J., Drew, P., . . . Fenix, K. A. (2023). Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer, 11(4), e006764-1-e006764-17. DOI Scopus14 WoS4 Europe PMC11
2023	Shaghayegh, G., Cooksley, C., Bouras, G., Nepal, R., Houtak, G., Panchatcharam, B. S., . . . Vreugde, S. (2023). Staphylococcus aureus biofilm properties and chronic rhinosinusitis severity scores correlate positively with total CD4+ T-cell frequencies and inversely with its Th1, Th17 and regulatory cell frequencies. Immunology, 170(1), 120-133. DOI Scopus6 Europe PMC4
2023	Krishnan, S. T., Winkler, D., Creek, D., Anderson, D., Kirana, C., Maddern, G. J., . . . Voelcker, N. H. (2023). Staging of colorectal cancer using lipid biomarkers and machine learning.. Metabolomics, 19(10), 11 pages. DOI Scopus12 Europe PMC10
2022	Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages. DOI Scopus12 WoS7 Europe PMC12
2022	Mahnaz, R., Harrison, B., Hon, K., Gohar, S., Hadi, R., Aaron, F. K., . . . Sarah, V. (2022). Characterization of human nasal organoids from chronic rhinosinusitis patients.. Biology open, 11(8), 1-8. DOI Scopus3 WoS1 Europe PMC3
2021	Tyllis, T. S., Fenix, K. A., Norton, T. S., Kara, E. E., McKenzie, D. R., David, S. C., . . . Comerford, I. (2021). CXCR5⁺CD8⁺ T cells shape antibody responses In Vivo following protein immunisation and peripheral viral infection. Frontiers in Immunology, 12, 626199-1-626199-14. DOI Scopus13 WoS8 Europe PMC11
2021	Balakrishnan, B., Liang, Q., Fenix, K., Tamang, B., Hauben, E., Ma, L., & Zhang, W. (2021). Combining the anticancer and immunomodulatory effects of astragalus and shiitake as an integrated therapeutic approach. Nutrients, 13(8), 16 pages. DOI Scopus27 WoS11 Europe PMC17
2020	Whyte, C. E., Osman, M., Kara, E. E., Abbott, C., Foeng, J., McKenzie, D. R., . . . McColl, S. R. (2020). ACKR4 restrains antitumor immunity by regulating CCL21. Journal of Experimental Medicine, 217(6), 1-S4. DOI Scopus29 WoS18 Europe PMC26
2020	Goggin, R., Bennett, C., Ramezanpour, M., Hu, H., Fenix, K., Bassiouni, A., . . . Vreugde, S. (2020). Association between viral infection and increased mucosal eosinophils and CD8<sup>+</sup>CD103<sup>+</sup> T cells in chronic rhinosinusitis. International Forum of Allergy and Rhinology, 10(8), 978-980. DOI
2020	Fenix, K., Wijesundara, D. K., Cowin, A. J., Grubor-Bauk, B., & Kopecki, Z. (2020). Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis.. Int J Mol Sci, 21(19), 13 pages. DOI Scopus26 WoS14 Europe PMC19
2018	Kara, E. E., Bastow, C. R., McKenzie, D. R., Whyte, C. E., Fenix, K. A., Babb, R., . . . McColl, S. R. (2018). Atypical chemokine receptor 4 shapes activated B cell fate. Journal of Experimental Medicine, 215(3), 801-813. DOI Scopus20 WoS16 Europe PMC19
2017	McKenzie, D., Kara, E., Bastow, C., Tyllis, T., Fenix, K., Gregor, C., . . . McColl, S. (2017). IL-17-producing γδ T cells switch migratory patterns between resting and activated states. Nature Communications, 8(1), 15632-1-15632-13. DOI Scopus96 WoS79 Europe PMC85
2016	Leong, Y., Chen, Y., Ong, H., Wu, D., Man, K., Deleage, C., . . . Yu, D. (2016). CXCR5⁺ follicular cytotoxic T cells control viral infection in B cell follicles. Nature Immunology, 17(10), 1187-1196. DOI Scopus376 WoS308 Europe PMC349
2015	Kara, E., McKenzie, D., Bastow, C., Gregor, C., Fenix, K., Ogunniyi, A., . . . McColl, S. (2015). CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells. Nature Communications, 6(1), 8644-1-8644-1 7. DOI Scopus112 WoS96 Europe PMC95
2014	Kara, E., Comerford, I., Fenix, K., Bastow, C., Gregor, C., McKenzie, D., & McColl, S. (2014). Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathogens, 10(2), 1003905-1-1003905-15. DOI Scopus70 WoS55 Europe PMC49
2013	Kara, E., Comerford, I., Bastow, C., Fenix, K., Litchfield, W., Handel, T., & McColl, S. (2013). Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. Journal of Immunology, 191(3), 1110-1117. DOI Scopus54 WoS46 Europe PMC42
2010	Comerford, I., Bunting, M., Fenix, K., Haylock-Jacobs, S., Litchfield, W., Harata-Lee, Y., . . . McColl, S. (2010). An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation? CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays, 32(12), 1067-1076. DOI Scopus100 WoS90 Europe PMC84
-	Krishnan, S. T., Rudd, D., Rahmani, R., Antunez, E. E., Minhas, R. S., Kirana, C., . . . Voelcker, N. H. (n.d.). Nanostructured Silicon Enabled HR-MS for the Label-Free Detection of Biomarkers in Colorectal Cancer Plasma Small Extracellular Vesicles. Journal of Nanotheranostics, 3(4), 189-202. DOI

Conference Papers

Year	Citation
2017	Gregor, C. E., Kara, E. E., Fenix, K. A., McKenzie, D. R., Comerford, I., & McColl, S. R. (2017). Effector T helper cell recruitment to inflammatory sites via CCR2. In SWISS MEDICAL WEEKLY Vol. 147 (pp. 64S). E M H SWISS MEDICAL PUBLISHERS LTD.

Conference Items

Year	Citation
2016	McKenzie, D., Kara, E., Tyllis, T., Bastow, C., Fenix, K., Gregor, C., . . . McColl, S. (2016). Dynamic expression of CCR6 and CCR2 balances homeostatic and inflammatory trafficking of γδT17 cells. Poster session presented at the meeting of EUROPEAN JOURNAL OF IMMUNOLOGY. Melbourne, AUSTRALIA: WILEY-BLACKWELL.
2016	Kara, E., Bastow, C., Mckenzie, D., Gregor, C., Fenix, K., Norton, T., . . . Mccoll, S. (2016). The atypical chemokine receptor ACKR4 shapes early antibody responses. Poster session presented at the meeting of EUROPEAN JOURNAL OF IMMUNOLOGY. Melbourne, AUSTRALIA: WILEY-BLACKWELL.

Preprint

Year	Citation
2024	Yeo, K., Wu, F., Li, R., Smith, E., Wormald, P. -J., Valentine, R., . . . Fenix, K. (2024). Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?. DOI
2024	Li, C. M. Y., Briggs, M., Lee, Y. -R., Tin, T., Young, C., Pierides, J., . . . Fenix, K. (2024). Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases. DOI
2024	Li, R., Liu, S., Yeo, K., Edwards, S., Li, M. Y., Santos, R., . . . Smith, E. (2024). Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease. DOI
2024	Yeo, K., Connell, J., Bouras, G., Smith, E., Murphy, W., Hodge, J. -C., . . . Fenix, K. A. (2024). A comparison between full-length 16S rRNA Oxford Nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues. DOI
2024	Burdon, I., Bouras, G., Fenix, K., Yeo, K., Connell, J., Cooksley, C., . . . Psaltis, A. J. (2024). Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome. DOI
2023	Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2023). Identification of consensus head and neck cancer-associated microbiota signatures: a meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. DOI
2023	Ying Li, C. M., Tomita, Y., Dhakal, B., Tin, T., Li, R., Wright, J. A., . . . Fenix, K. (2023). Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases. DOI

Dr Kevin Fenix is a recipient of multiple competitive research funding awards (>$2million) from Cancer Council SA, Tour de Cure, Cure Cancer Australia, the Ray and Shirl Norman Trust, and The Hospital Research Foundation Group.

A selection of competitive funding awards are listed below:

Competitive Research Grants
Year	Title	Investigators	Amount
2020	Pre-clinical assessment of a patient-derived cellular immunotherapy for metastatic colorectal cancer.	Fenix K.	$50,000
2019	Construction of the South Australian Liver Tissue-Biobank (SALT) for discovery and development of prognostic biomarkers of colorectal cancer liver metastasis. (Beat Cancer SA and The Hospital Research Foundation)	Maddern G., Fenix K.	$200,000
2019	Purchase of a fluorescent and bright-field automated cell counter. (Faculty of Health and Medical Sciences Research Infrastructure Funding Award and The Basil-Hetzel Institute Research Equipment Award)	Maddern G., Fenix K., Wormald P., Grubor-Bauk B.	$22,703
2018	Study of bioactivity of Hengshan Astragalus Shiitake as biological response modifiers in cancer therapy ( Flinders University Innovation Patnership Seed Grant and Shanxi Yulongxiang agricultural development Co., Ltd)	Ma L., Fenix K., Hauben E., Liang Q.	$100,000
2018	Identification of a Diagnostic Marker for Assessment and Management of Psoriasis. ( New Adventures Fund UniSA and The Hospital Research Foundation )	Grubor-Bauk B., Wijesundara D., Fenix K., Kopecki Z.	$28,619
2018	Using Tissue-Resident T cells to develop new prognostics and treatments against bowel cancer. ( The Hospital Research Foundation Early Career Fellowship)	Fenix K.	$240,000

Travel Awards
Year	Source	Conference	Amount
2019	Faculty of Health and Medical Sciences	Lorne Cancer Conference (2019)	$1000
2017	Australasian Society for Immunology	46th Annual Scientific Meeting of Australasian Society for Immunology (Brisbane, Australia)	$1400
2016	International Congress of Immunology	International Congress of Immunology 2016 (Melbourne, Australia)	$1000
2014	School of Molecular and Biomedical Science and Australasian Society for Immunology	Annual Scientific Meeting of Australasian Society for Immunology (Wollongong, Australia)	$1500

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2024	Principal Supervisor	The development of more effective next-generation cytokine-induced killer cell therapies for the improved treatment of metastatic colorectal cancer	Doctor of Philosophy	Doctorate	Full Time	Mrs Elham Shokati
2023	Principal Supervisor	Target the tumour microbiome to improve head & neck cancer treatment outcomes	Doctor of Philosophy	Doctorate	Full Time	Mrs Lee Mai
2023	Co-Supervisor	Repurposing the anti-anginal drug perhexiline for the treatment of cancer	Doctor of Philosophy	Doctorate	Full Time	Ms Fangmeinuo Wu
2022	Co-Supervisor	Over-expression of SFRP5 in hepatocytes: a novel treatment strategy for colorectal cancer liver metastases	Doctor of Philosophy	Doctorate	Full Time	Mr Runhao Li
2022	Co-Supervisor	The role of various Staphylococcus species in eliciting inflammation in Chronic rhinosinusitis	Doctor of Philosophy	Doctorate	Full Time	Mr Sintayehu Ambachew Wondemagegn

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2021 - 2024	Co-Supervisor	Characterising the Microbiome and its Diagnostic and Prognostic Value in Head and Neck Cancer	Doctor of Philosophy	Doctorate	Full Time	Mr Kenny Ker Li Yeo
2021 - 2022	Co-Supervisor	Perhexiline as a Potential Treatment for Colorectal Cancer	Doctor of Philosophy	Doctorate	Full Time	Mrs Bimala Dhakal
2020 - 2024	Co-Supervisor	INVESTIGATION OF CYTOKINE-INDUCED KILLER CELL THERAPY FOR THE TREATMENT OF COLORECTAL CANCER LIVER METASTASIS	Doctor of Philosophy	Doctorate	Full Time	Miss Man Ying Li

Committee Memberships

Date	Role	Committee	Institution	Country
2019 - ongoing	Member	BHI IBC Biosafety Committee	BHI	Australia
2018 - ongoing	Member	Basil-Hetzel Institute Management Committee	Basil-Hetzel Institute for Translational Health Research	Australia
2017 - ongoing	Member	Adelaide Immunology Retreat Organzing Committee	Australasian Soceity for Immunology	Australia
2017 - ongoing	Member	Day of Immunology (Adelaide) Organizing Committee	Australsian Society for Immunology	Australia

Memberships

Date	Role	Membership	Country
2018 - ongoing	Member	Australasian Cytometry Society	Australia
2018 - ongoing	Member	Australasian Gastro-Intestinal Trials Group	Australia
2018 - ongoing	Member	Cancer Voices SA	Australia
2013 - ongoing	Member	Australasian Society for Immunology	Australia

Community Engagement

Date	Title	Engagement Type	Institution	Country
2018 - ongoing	Invited Speaker for The Longest Table Events	Public Community Engagement	The Hospital Research Foundation	Australia
2018 - ongoing	Science Alive! Booth Volunteer (BHI)	Public Community Engagement	Basil Hetzel Institute for Translational Health Research	Australia
2018 - ongoing	Newsletter Article in The Hospital Research Foundation	Public Community Engagement	The Hospital Research Foundation	-
2018 - ongoing	Radio Interview for Coast FM	Public Community Engagement	The Hospital Research Foundation	Australia
2018 - ongoing	Invited Speaker for the Day of Immunology BHI Lab Tour	Public Community Engagement	Australasian Society for Immunology	Australia

Editorial Boards

Date Role Editorial Board Name Institution Country

2018 - ongoing Editor Frontiers in Cellular and Infection Microbiology The University of Adelaide Australia

Date	Role	Editorial Board Name	Institution	Country
2018 - ongoing	Editor	Frontiers in Cellular and Infection Microbiology	The University of Adelaide	Australia

Position: Research Fellow
Email: kevin.fenix@adelaide.edu.au
Org Unit: Medical Studies

Dr Kevin Fenix

Appointments

Awards and Achievements

Language Competencies